Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia

Christian, PhD, B. T. D2/D3 Dopamine Receptor Binding With [F-18]fallypride Correlates of Executive Function in Medication-naïve Patients With Schizophrenia.

Vyas NS, Buchsbaum MS, Lehrer DS, Merrill BM, DeCastro A, Doninger NA, Christian BT, Mukherjee J. (2018). D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia. Schizophrenia Research, 192:442-456. doi: 10.1016/j.schres.2017.05.017.